Document is current
Any future updates will be listed below
-
Authors
Wollmuth, Jason R.
Bharadwaj, Aditya S.
Noor, Nudrat
Almedhychy, Ali
O’Neill, William
-
Funding
Funding for this research was provided by:
Johnson and Johnson
Abiomed
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 18 November 2025
First Online: 13 December 2025
Declarations
:
: Jason R. Wollmuth reports speaking and consulting honoraria from Johnson & Johnson/Abiomed, Abbott Vascular, Boston Scientific, and Shockwave Medical. Aditya S. Bharadwaj reports speaking and consulting honoraria from Johnson & Johnson/Abiomed, Shockwave Medical, and Abbott CSI. Nudrat Noor and Ali Almedhychy are employees of Johnson & Johnson MedTech. William O’Neill reports consultancy and research support from Johnson & Johnson, Edwards Lifesciences, Boston Scientific, Abbott, and Zoll.
: This observational cohort study used only de-identified patient records obtained from the Truveta electronic health record platform. As such, it did not require institutional review board approval or informed consent, in accordance with the Common Rule and applicable US federal regulations. De-identification was verified through expert determination consistent with the Health Insurance Portability and Accountability Act Privacy Rule. The study was conducted in accordance with the principles of the Declaration of Helsinki (1964) and its later amendments.
